{"name": "Ultragenyx Pharmaceutical",
 "permalink": "ultragenyx-pharmaceutical",
 "crunchbase_url": "http://www.crunchbase.com/company/ultragenyx-pharmaceutical",
 "homepage_url": "http://www.ultragenyx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@ultragenyx.com",
 "phone_number": "415.884.0223 x107",
 "description": "",
 "created_at": "Tue Jun 21 02:30:43 UTC 2011",
 "updated_at": "Fri Jan 11 13:20:49 UTC 2013",
 "overview": "\u003Cp\u003EUltragenyx\u00e2\u201e\u00a2 develops therapeutics for rare diseases, sometimes referred to as Orphan products. Founded in 2010, the company is led by Emil Kakkis, M.D., Ph.D., former CMO of BioMarin Pharmaceutical. Efficient and effective development strategies are essential for success in the rare disease space, in which information may be incomplete or ambiguous, and few development precedents exist. The management team\u00e2\u20ac\u2122s experience in selecting and developing products with clear mechanisms of action for untreated rare diseases will help Ultragenyx create life-changing therapeutics by leveraging existing yet undeveloped science for these little-known indications.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       57],
      "assets/images/resized/0014/0132/140132v1-max-150x150.png"],
     [[210,
       80],
      "assets/images/resized/0014/0132/140132v1-max-250x250.png"],
     [[210,
       80],
      "assets/images/resized/0014/0132/140132v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Emil",
      "last_name": "D. Kakkis",
      "permalink": "emil-d-kakkis",
      "image": null}},
   {"is_past": false,
    "title": "SVP Finance \u0026 CFO",
    "person":
     {"first_name": "Shalini",
      "last_name": "Sharp",
      "permalink": "shalini-sharp",
      "image": null}},
   {"is_past": false,
    "title": "Chief Business Officer and Senior Vice President",
    "person":
     {"first_name": "Thomas",
      "last_name": "Kassberg",
      "permalink": "thomas-kassberg",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$45M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2011/06/ultragenyx-pharmaceutical-closes-45m-series-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Ultragenyx Pharmaceutical Closes $45M Series A Financing",
    "raised_amount": 45000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 6,
    "funded_day": 20,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "TPG Biotechnology Partners",
         "permalink": "tpg-biotechnology-partners",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Fidelity Biosciences",
         "permalink": "fidelity-biosciences-2",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/0044/50044v1-max-150x150.png"],
             [[233,
               79],
              "assets/images/resized/0005/0044/50044v1-max-250x250.png"],
             [[233,
               79],
              "assets/images/resized/0005/0044/50044v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pappas Ventures",
         "permalink": "pappas-ventures",
         "image":
          {"available_sizes":
            [[[150,
               131],
              "assets/images/resized/0004/9245/49245v1-max-150x150.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-250x250.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "77 Digital Drive",
    "address2": "Suite 210 ",
    "zip_code": "94949",
    "city": "Novato",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}